E

Exact Sciences Corp
D

EXAS

53.090
USD
0.37
(0.70%)
Market Closed
Volume
0
EPS
-1
Div Yield
-
P/E
-56
Market Cap
9,809,431,974
OverviewSignalsIdeasNews
Related Instruments
    A
    ALGN
    2.230
    (1.01%)
    223.930 USD
    I
    ILMN
    -7.180
    (-5.05%)
    135.110 USD
    ISRG
    ISRG
    -10.30
    (-1.92%)
    550.64 USD
    N
    NVCR
    -0.470
    (-2.83%)
    16.120 USD
    P
    PODD
    -0.83
    (-0.32%)
    260.18 USD
    R
    RGEN
    -17.400
    (-12.22%)
    124.960 USD
    T
    TDOC
    0.23500
    (2.62%)
    9.19500 USD
    T
    TECH
    -4.920
    (-6.79%)
    67.590 USD
    V
    VEEV
    -16.200
    (-7.06%)
    213.260 USD
    More
News

Title: Exact Sciences Corp

Sector: Healthcare
Industry: Diagnostics & Research
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.